Image de couverture de livre

Thromboembolic Risk of Thrombopoietin Receptor Agonists for Adult Primary Immune Thrombocytopenia: A Systematic Review and Meta‐Analysis Integrating Randomized Controlled Trials and Prospective Evidence

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Meng‐Fei Dai, Gao‐Wei Chong, Wen‐Xiu Xin, Si‐Si Kong, Jun‐Feng Zhu, Li‐Ke Zhong, Gao‐Qi Xu, Xiang‐Yu Jin, Chao‐Neng He, Ting‐Ting Wang, Xiu‐Fang Mi, Liping Luo, Zhu‐Jin Song, Hai‐Ying Ding, Luo Fang
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Impact of Glucagon‐Like Peptide‐1 Receptor Agonists on Proteinuria in Kidney Transplant Recipients
par: Stephanie Shabanowitz, et autres
Publié: (2026)

Real‐World Cardiovascular Outcomes of GLP ‐1 Receptor Agonists in Women With Type 2 Diabetes and Breast Cancer
par: Cyrille K. Cornelio, et autres
Publié: (2026)

SGLT2 Inhibitors and GLP‐1 Receptor Agonists After Acute Kidney Injury: A Systematic Review With Meta‐Analysis
par: Erin F. Barreto, et autres
Publié: (2026)

Beyond Monotherapy: The Superior Efficacy of Combined GLP ‐1 Receptor Agonist and SGLT2 Inhibitors on Renal Biomarkers: A Systematic Review and Meta‐Analysis
par: Aya M. AbdelMagid, et autres
Publié: (2026)

Circulating Profiles of the Bile Acid Metabolomics in Patients With Polycystic Ovary Syndrome Treated With Metformin or Canagliflozin
par: Qi Yan, et autres
Publié: (2025)

Immune Checkpoint Inhibitor Exposure During Pregnancy: A Systematic Review
par: Casey L. Keller, et autres
Publié: (2026)

Prescription Sequence Symmetry Analysis for Detection of Chronic Opioid Use Adverse Event Signals Using Administrative Claims Data
par: Efstathia Polychronopoulou, et autres
Publié: (2025)

High‐Throughput Screening for Prescribing Cascades Among Real‐World Angiotensin‐ II Receptor Blockers ( ARBs ) Initiators
par: Asinamai M. Ndai, et autres
Publié: (2025)

DILIConsult : A Multi‐Agent Large Language Model Framework for Evaluating Drug‐Induced Liver Injury in ICU Settings
par: Alfred Zheng Ting Ho, et autres
Publié: (2026)

Correlation Between Analgesic and Sedative Drug Withdrawal and Salivary Cortisol Levels in Children in PICUs : A Prospective Cohort Study
par: Yaping Zhan, et autres
Publié: (2025)

Intraperitoneal Granisetron for Post‐Laparoscopic Cholecystectomy Pain Management: A Double‐Blinded, Randomized Controlled Trial
par: Hoda Mohamed Bayoumi, et autres
Publié: (2025)

Probiotic Supplementation as an Adjuvant Therapy in Pediatric Drug‐Resistant Epilepsy: A Double‐Blind Placebo‐Controlled Trial
par: Amira R. Rashdan, et autres
Publié: (2026)

Risk of acute kidney injury in dapagliflozin users with type 2 diabetes: A nationwide propensity score‐matched cohort study in Korea
par: Hee‐Jin Kim, et autres
Publié: (2025)

A Multicenter, Open‐Label Study to Assess the Safety of Nebulized Tissue Plasminogen Activator for the Acute Treatment of Pediatric Plastic Bronchitis: The PLATyPuS Trial
par: Kathleen A. Stringer, et autres
Publié: (2025)

Development and Validation of a Time‐Dependent Nomogram for Predicting Hematological Toxicity Risk During Linezolid Therapy in Drug‐Resistant Tuberculosis
par: Wenqiang Zhou, et autres
Publié: (2026)

Effect of proton pump inhibitors versus histamine‐2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers
par: Hua‐Ping Fan, et autres
Publié: (2024)

Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population
par: Alexandre Duong, et autres
Publié: (2024)

Thrombosis Across Female‐Specific Malignancies: From Chemotherapy‐Driven Risk to Prophylaxis and Drug Interactions
par: Maryam Aghakouchakzadeh, et autres
Publié: (2026)

Cancer Treatment Modalities and Female Fertility Preservation
par: Seonga Song, et autres
Publié: (2026)

Aztreonam–avibactam: The dynamic duo against multidrug‐resistant gram‐negative pathogens
par: Mohammed Al Musawa, et autres
Publié: (2024)

Response to comment on “Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report”
par: Atif Siddiqui
Publié: (2025)

Managing attention‐deficit/hyperactivity disorder in a breastfeeding mother: A case report
par: Jiwon Kim, et autres
Publié: (2025)

Pharmacokinetic and Pharmacodynamic Principles and Concepts Remain Relevant in the Era of Artificial Intelligence and Machine Learning
par: Keith A. Rodvold
Publié: (2026)

Cross‐titration from risperidone to clozapine utilizing clozapine serum concentrations: A case report
par: Nicolette Centanni, et autres
Publié: (2025)

Association of Pneumonia, Fracture, Metabolic, and Renal Events With Long‐Term Proton Pump Inhibitor Use in Patients With Chronic Kidney Disease
par: Yi‐Fan Chien, et autres
Publié: (2025)

Developing a Statistical Modeling‐Based Machine Learning Approach for Capturing Drug Dosing Using a Proton Pump Inhibitor Case
par: Amanda Massmann, et autres
Publié: (2025)

In Search of Big Beautiful Biomarkers
par: C. Lindsay DeVane
Publié: (2025)

“Comment on ‘international consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the infectious diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists’”
par: Carlos Augusto Espinoza Cobeñas
Publié: (2024)

Response to comment on “International consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”
par: Lisa T. Hong, et autres
Publié: (2024)

Genome‐wide associations with metabolic syndrome among UK Biobank participants reporting use of second‐generation antipsychotics
par: Nihal El Rouby, et autres
Publié: (2025)

Evaluation of hyponatremia among older adults exposed to selective serotonin reuptake inhibitors and thiazide diuretics
par: Trisha Matsuura, et autres
Publié: (2025)

Update on the clinical applications of SGLTis: Insight to benefits beyond hypoglycemic and cardiorenal protection
par: Shibing Tao, et autres
Publié: (2024)

Oral β‐Lactams for Complicated Urinary Tract Infections: A Systematic Review and Point‐Counterpoint Comparison With Trimethoprim/Sulfamethoxazole and Fluoroquinolones
par: Ashlan J. Kunz Coyne, et autres
Publié: (2026)

Current and Emerging Pharmacologic Therapies for Diabetic Retinopathy
par: Jennifer N. Clements, et autres
Publié: (2026)

Pharmacokinetic Analysis of Intravenous Push Cefepime in Critically Ill Patients With Sepsis
par: Susan E. Smith, et autres
Publié: (2026)

Issue Information
Publié: (2026)

External evaluation of neonatal vancomycin population pharmacokinetic models: Moving from first‐order equations to Bayesian‐guided therapeutic monitoring
par: Mathieu Blouin, et autres
Publié: (2024)

Pharmaceutical Considerations for Oncology Risk, Screening, and Drug Dosing in the Transgender Population
par: Amy Broadwater, et autres
Publié: (2026)

The efficacy and safety of sodium‐glucose cotransporter‐2 inhibitors in solid organ transplant recipients: A scoping review
par: Hansa Mreyoud, et autres
Publié: (2024)

Treatment Adherence to Oral Direct‐Acting Antiviral Agents in Hepatitis C Infection
par: Javeria Khalid, et autres
Publié: (2026)